199 related articles for article (PubMed ID: 12426785)
1. [Investigation of vasoactive agents with indole skeletons at Richter Ltd].
Kárpáti E; Bíró K; Kukorelli T
Acta Pharm Hung; 2002; 72(1):25-36. PubMed ID: 12426785
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of neuromuscular blocking agents at Richter Ltd].
Kárpáti E; Bíró K; Kukorelli T
Acta Pharm Hung; 2002; 72(1):37-48. PubMed ID: 12426786
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
4. [About cavinton therapy of the patients with brain vascular diseases].
Nikitina VV; Pravdina AN; Zapatrina OV
Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
[No Abstract] [Full Text] [Related]
5. [Mechanism of action of vinpocetine].
Kiss B; Kárpáti E
Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
[TBL] [Abstract][Full Text] [Related]
6. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
Witzmann HK; Blechacz W
Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
[No Abstract] [Full Text] [Related]
7. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
Franzini C; Ferrante P
Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
[No Abstract] [Full Text] [Related]
8. [Changes in the condition for the use of Cavinton and Devincan. New regulation concerning the prescription and use of these 2 drugs].
Orv Hetil; 1980 Jun; 121(25):1525-6. PubMed ID: 7454263
[No Abstract] [Full Text] [Related]
9. Eburnamine derivatives and the brain.
Vas A; Gulyás B
Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
[TBL] [Abstract][Full Text] [Related]
10. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
Periti P; Periti G; Colombo Pirola L
Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
[No Abstract] [Full Text] [Related]
11. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
Schenker H
Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
[No Abstract] [Full Text] [Related]
12. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
Riccardi T; Passeri F; Locatelli F
Minerva Med; 1978 Sep; 69(42):2873-8. PubMed ID: 358021
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
Dekoninck WJ; Jocquet P; Jacquy J; Henriet M
Arzneimittelforschung; 1978; 28(9):1654-7. PubMed ID: 383107
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
[TBL] [Abstract][Full Text] [Related]
15. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
[TBL] [Abstract][Full Text] [Related]
16. [Vincamine in the therapy of cerebral vascular diseases in the aged].
De Candia O; Bartolucci E; Mancinella A; Baghiris D
Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
[No Abstract] [Full Text] [Related]
17. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Dézsi L; Kis-Varga I; Nagy J; Komlódi Z; Kárpáti E
Acta Pharm Hung; 2002; 72(2):84-91. PubMed ID: 12498034
[TBL] [Abstract][Full Text] [Related]
19. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
Holemans P
Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
[No Abstract] [Full Text] [Related]
20. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
Mikus P
Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
